The application of discriminant analysis and Machine Learning methods as tools to identify and classify compounds with potential as transdermal enhancers.

Discriminant analysis (DA) has previously been shown to allow the proposal of simple guidelines for the classification of 73 chemical enhancers of percutaneous absorption. Pugh et al. employed DA to classify such enhancers into simple categories, based on the physicochemical properties of the enhancer molecules (Pugh et al., 2005). While this approach provided a reasonable accuracy of classification it was unable to provide a consistently reliable estimate of enhancement ratio (ER, defined as the amount of hydrocortisone transferred after 24h, relative to control). Machine Learning methods, including Gaussian process (GP) regression, have recently been employed in the prediction of percutaneous absorption of exogenous chemicals (Moss et al., 2009; Lam et al., 2010; Sun et al., 2011). They have shown that they provide more accurate predictions of these phenomena. In this study several Machine Learning methods, including the K-nearest-neighbour (KNN) regression, single layer networks, radial basis function networks and the SVM classifier were applied to an enhancer dataset reported previously. The SMOTE sampling method was used to oversample chemical compounds with ER>10 in each training set in order to improve estimation of GP and KNN. Results show that models using five physicochemical descriptors exhibit better performance than those with three features. The best classification result was obtained by using the SVM method without dealing with imbalanced data. Following over-sampling, GP gives the best result. It correctly assigned 8 of the 12 "good" (ER>10) enhancers and 56 of the 59 "poor" enhancers (ER<10). Overall success rates were similar. However, the pharmaceutical advantages of the Machine Learning methods are that they can provide more accurate classification of enhancer type with fewer false-positive results and that, unlike discriminant analysis, they are able to make predictions of enhancer ability.

[1]  Majella E Lane,et al.  Skin penetration enhancers. , 2013, International journal of pharmaceutics.

[2]  M T D Cronin,et al.  Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. , 2002, Toxicology in vitro : an international journal published in association with BIBRA.

[3]  J Hadgraft,et al.  Epidermal permeability-penetrant structure relationships: 4, QSAR of permeant diffusion across human stratum corneum in terms of molecular weight, H-bonding and electronic charge. , 2000, International journal of pharmaceutics.

[4]  M. Player,et al.  Transdermal and dermal enhancing activity of pyrrolidinones in hairless mouse skin , 1997 .

[5]  G P Moss,et al.  Discriminant analysis as a tool to identify compounds with potential as transdermal enhancers , 2005, The Journal of pharmacy and pharmacology.

[6]  Carl E. Rasmussen,et al.  Gaussian processes for machine learning , 2005, Adaptive computation and machine learning.

[7]  Neil Davey,et al.  The application of feature selection to the development of Gaussian process models for percutaneous absorption , 2010, The Journal of pharmacy and pharmacology.

[8]  Alexander J. Smola,et al.  Learning with Kernels: support vector machines, regularization, optimization, and beyond , 2001, Adaptive computation and machine learning series.

[9]  M. Player,et al.  In vitro evaluation of a series of Azone analogs as dermal penetration enhancers. II: (Thio) amides , 1993 .

[10]  J. Hadgraft,et al.  Mechanism of action of Azone as a percutaneous penetration enhancer: Lipid bilayer fluidity and transition temperature effects , 1988 .

[11]  Michael H. Abraham,et al.  Scales of solute hydrogen-bonding: their construction and application to physicochemical and biochemical processes , 2010 .

[12]  P Buchwald,et al.  A simple, predictive, structure‐based skin permeability model , 2001, The Journal of pharmacy and pharmacology.

[13]  J. Platts,et al.  Hydrogen bond structural group constants. , 2001, The Journal of organic chemistry.

[14]  Mark T D Cronin,et al.  Quantitative structure-permeability relationships for percutaneous absorption: re-analysis of steroid data. , 2002, International journal of pharmaceutics.

[15]  Vipin Kumar,et al.  Evaluating boosting algorithms to classify rare classes: comparison and improvements , 2001, Proceedings 2001 IEEE International Conference on Data Mining.

[16]  Neil Davey,et al.  The application of stochastic machine learning methods in the prediction of skin penetration , 2011, Appl. Soft Comput..

[17]  D. W. Van Krevelen,et al.  Cohesive Properties and Solubility , 2009 .

[18]  K. Larsson,et al.  On the effect of urea on human epidermis. , 1974, Dermatologica.

[19]  Nitesh V. Chawla,et al.  SMOTE: Synthetic Minority Over-sampling Technique , 2002, J. Artif. Intell. Res..

[20]  R. Latour,et al.  Evaluation of derivatives of 3-(2-oxo-1-pyrrolidine)hexahydro-1H-azepine-2-one as dermal penetration enhancers: side chain length variation and molecular modeling. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[21]  J E Riviere,et al.  Modelling the effect of mixture components on permeation through skin. , 2010, International journal of pharmaceutics.

[22]  Michael H. Abraham,et al.  Linear solvation energy relationships. 23. A comprehensive collection of the solvatochromic parameters, .pi.*, .alpha., and .beta., and some methods for simplifying the generalized solvatochromic equation , 1983 .

[23]  M. Cronin,et al.  Pitfalls in QSAR , 2003 .

[24]  M. Player,et al.  Synthesis and investigation of urea compounds as transdermal penetration enhancers , 1998 .

[25]  S. Singh,et al.  Transdermal drug delivery by passive diffusion and iontophoresis: A review , 1993, Medicinal research reviews.

[26]  Neil Davey,et al.  The application of Gaussian processes in the prediction of percutaneous absorption , 2009, ESANN.

[27]  G P Moss,et al.  Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[28]  Taravat Ghafourian,et al.  The effect of penetration enhancers on drug delivery through skin: a QSAR study. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Michael S. Roberts,et al.  Simple Rules Defining the Potential of Compounds for Transdermal Delivery or Toxicity , 2004, Pharmaceutical Research.

[30]  Christopher M. Bishop,et al.  Neural networks for pattern recognition , 1995 .

[31]  J. Hadgraft,et al.  Mixed monolayers of dipalmitoylphosphatidylcholine with Azone or oleic acid at the air-water interface , 1990 .

[32]  M D Barratt,et al.  Quantitative structure-activity relationships for skin permeability. , 1995, Toxicology in vitro : an international journal published in association with BIBRA.

[33]  Russell O. Potts,et al.  A Predictive Algorithm for Skin Permeability: The Effects of Molecular Size and Hydrogen Bond Activity , 1995, Pharmaceutical Research.

[34]  Russell O. Potts,et al.  Predicting Skin Permeability , 1992, Pharmaceutical Research.

[35]  Michael H. Abraham,et al.  LINEAR SOLVATION ENERGY RELATIONSHIPS. 23. A COMPREHENSIVE COLLECTION OF THE SOLVATOCHROMIC PARAMETERS, Π*, α, AND β, AND SOME METHODS FOR SIMPLIFYING THE GENERALIZED SOLVATOCHROMIC EQUATION , 1984 .

[36]  H. Maibach,et al.  Classification of percutaneous penetration enhancers: A conceptional diagram , 1990, The Journal of pharmacy and pharmacology.

[37]  R. F. Fedors,et al.  A method for estimating both the solubility parameters and molar volumes of liquids , 1974 .

[38]  J. Fletcher,et al.  Factors affecting the permeability of skin. The relation between in vivo and in vitro observations. , 1978, Current problems in dermatology.

[39]  L. Strekowski,,et al.  Percutaneous penetration enhancement activity of aromatic S, S-dimethyliminosulfuranes. , 1999, International journal of pharmaceutics.

[40]  J. Fletcher,et al.  Factors Affecting the Permeability of Skin , 1978 .

[41]  M. Player,et al.  In vitro evaluation of azone analogs as dermal penetration enhancers: V. Miscellaneous compounds , 1998 .

[42]  Fumiyoshi Yamashita,et al.  Prediction of human skin permeability using a combination of molecular orbital calculations and artificial neural network. , 2002, Biological & pharmaceutical bulletin.

[43]  Taravat Ghafourian,et al.  Validated models for predicting skin penetration from different vehicles. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[44]  Asbill,et al.  Percutaneous penetration enhancers: local versus transdermal activity. , 2000, Pharmaceutical science & technology today.

[45]  M. Abraham,et al.  Algorithms for Skin Permeability Using Hydrogen Bond Descriptors: the Problem of Steroids * , 1997, The Journal of pharmacy and pharmacology.

[46]  Jonathan Hadgraft,et al.  Ab initio prediction of human skin permeability coefficients , 1994 .

[47]  A. Nokhodchi,et al.  The enhancement effect of surfactants on the penetration of lorazepam through rat skin. , 2003, International journal of pharmaceutics.

[48]  Fredric C. Gey,et al.  The relationship between recall and precision , 1994 .